Oblimersen: Augmerosen, BCL-2 Antisense Oligonucleotide - Genta, G 3139, GC 3139, Oblimersen Sodium

ISSN： 1174-5886

Source： Drugs in R&D, Vol.8, Iss.5, 2007-01, pp. : 321-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

G 3139: Augmerosen, Bcl-2 Antisense Oligonucleotide - Genta, GC 3139, Genasense

Drugs in R&D, Vol. 3, Iss. 1, 2002-01 ,pp. : 44-49

Adis International

Access to resources Recommend Favorite

Transferrin Receptor Targeted Lipopolyplexes for Delivery of Antisense Oligonucleotide G3139 in a Murine K562 Xenograft Model

By Zhang Xulang Koh Chee Yu Bo Liu Shujun Piao Longzhu Marcucci Guido Lee Robert Lee L.

Pharmaceutical Research, Vol. 26, Iss. 6, 2009-06 ,pp. : 1516-1524

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic evaluation of oblimersen sodium for the treatment of chronic lymphocytic leukemia

By Advani Pooja P Paulus Aneel Masood Ayesha Sher Taimur Chanan-Khan Asher

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 6, 2011-06 ,pp. : 765-774

Informa Healthcare

Access to resources Recommend Favorite

Oblimersen feasible in relapsed multiple myeloma

Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Oblimersen sets the scene for survival in CLL

Inpharma, Vol. 1, Iss. 1619, 2008-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite